3M entered a broad resolution to settle approximately 99% of current per- or poly-fluoroalkyl substance (PFAS)-related personal injury claims, including those in the Aqueous Film-Forming Foam multidistrict litigation. The company will make a nominal commitment of $7.35 billion between 2026 and 2034, contingent on claimant participation thresholds. This agreement substantially reduces litigation uncertainty but requires a pre-tax charge of approximately $5.8 billion in the fourth quarter of 2026. 3M operates as a diversified technology company focused on creating innovative solutions across industrial, safety, and healthcare sectors.
